Show
Sort by
-
Cost considerations for monoclonal antibody-targeted therapy in cancer: focus on Trastuzumab
-
Economic evaluation of medical innovations
(2006) -
The long-term evolution of quality, of life for disease-free breast cancer survivors : a comparative study in Belgium
-
An economic evaluation of Herceptin((R)) in adjuvant setting: The Breast Cancer International Research Group 006 trial
-
- Miscellaneous
- open access
Bureaucratisation and the growth of health care expenditures in Europe
-
Cost-effectiveness of Herceptin (R): A standard cost model for breast-cancer treatment in a Belgian university hospital
-
Comparing the cost of delayed and immediate autologous breast reconstruction in Belgium